N

Nexeon Medsystems Inc
OTC:NXNN

Watchlist Manager
Nexeon Medsystems Inc
OTC:NXNN
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 197 USD

Nexeon Medsystems Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nexeon Medsystems Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
N
Nexeon Medsystems Inc
OTC:NXNN
Research & Development
-$2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Research & Development
-$1.9B
CAGR 3-Years
-14%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Research & Development
-$1.5B
CAGR 3-Years
-7%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.9B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-8%
IDEXX Laboratories Inc
NASDAQ:IDXX
Research & Development
-$242.1m
CAGR 3-Years
2%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.2B
CAGR 3-Years
-15%
CAGR 5-Years
-16%
CAGR 10-Years
-20%
No Stocks Found

Nexeon Medsystems Inc
Glance View

Market Cap
196.6 USD
Industry
Health Care

Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2017-08-01. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology. In addition, the Company is developing and commercializing NNS, an implantable neurostimulation and recording platform. The Company’s wholly-owned subsidiaries include Nexeon Medsystems Europe, SARL (Nexeon Europe), Nexeon Medsystems Puerto Rico Operating Company Corporation (NXPROC) and Pulsus Medical LLC.

NXNN Intrinsic Value
Not Available
N

See Also

What is Nexeon Medsystems Inc's Research & Development?
Research & Development
-2.9m USD

Based on the financial report for Dec 31, 2017, Nexeon Medsystems Inc's Research & Development amounts to -2.9m USD.

What is Nexeon Medsystems Inc's Research & Development growth rate?
Research & Development CAGR 1Y
-287%

Over the last year, the Research & Development growth was -287%.

Back to Top